跳至内容
Human immunodeficiency virus reverse transcriptase : a bench-to-bedside success 線上預覽
關閉線上預覽
正在查...

Human immunodeficiency virus reverse transcriptase : a bench-to-bedside success

作者: Stuart LeGrice; Matthias Götte
出版商: New York, NY : Springer, 2013.
版本/格式:   電子書 : 文獻 : 英語所有版本和格式的總覽
資料庫:WorldCat
提要:
The Reverse Transcriptase (RT) of Human Immunodeficiency Virus Type 1 (HIV-1) arguably ranks amongst one of the most extensively studied retroviral enzymes. Heterologous expression and purification of HIV-1 RT in the early eighties, approval of the first nucleoside analogue RT inhibitor (NRTI) in 1987, discovery of resistance to RT inhibitors, approval of the first non-nucleoside analogue RT inhibitor (NNRTI) in  再讀一些...
評定級別:

(尚未評分) 0 附有評論 - 成爲第一個。

主題
更多類似這樣的

 

在線上查詢

與資料的連結

在圖書館查詢

&AllPage.SpinnerRetrieving; 正在查詢有此資料的圖書館...

詳細書目

類型/形式: Electronic books
資料類型: 文獻, 網際網路資源
文件類型: 網路資源, 電腦資料
所有的作者/貢獻者: Stuart LeGrice; Matthias Götte
ISBN: 9781461472919 1461472911
OCLC系統控制編碼: 856550154
注意: Includes index.
描述: 1 online resource (x, 361 pages) : illustrations
内容: Development of the First AIDS Drugs: AZT and Other Dideoxynueosides / Robert Yarchoan, Hiroaki Mitsuya --
Part I: Structure and Function of HIV RT. Proviral DNA Synthesis in HIV: Background / Dorota Piekna-Przybylska Ph.D., Robert A. Bambara Ph.D. --
The RNase H Domain: Structure, Function and Mechanism / Marcin Nowotny, Małgorzata Figiel --
Conformational Dynamics of Reverse Transcription / Stuart F. J. LeGrice --
Part II: Mechanism of Action of Approved RT Inhibitors. Nucleoside RT Inhibitors: Structural and Molecular Biology / Gaofei Lu, Antonio J. Acosta-Hoyos, Walter A. Scott --
Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs) / Kalyan Das Ph.D., Eddy Arnold Ph.D., Stephen H. Hughes Ph.D. --
Part III: Alternative Strategies to Interfere with the Function of HIV RT. Ribonuclease H Inhibitors: Structural and Molecular Biology / Jason W. Rausch --
Targeting Small Molecules and Peptides to the p66-p51 Reverse Transcriptase Interface / Daouda Abba Moussa, Audrey Agopian, Gilles Divita --
Targeting RT Translocation / Gregory L. Beilhartz, Brian J. Scarth, Matthias Götte --
tRNA Primer Sequestration as an Antiviral Strategy / Christopher P. Jones, Karin Musier-Forsyth --
Part IV: HIV Genetic Variability and the Problem of Drug Resistance. HIV Reverse Transcriptase Fidelity, Clade Diversity, and Acquisition of Drug Resistance / Luis Menéndez-Arias --
APOBECs and Their Role in Proviral DNA Synthesis / John S. Albin, Reuben S. Harris --
Role of RNase H Activity in NRTI/NNRTI Drug Resistance / Gilda Tachedjian B.Sc. (Hons), Ph.D., Nicolas Sluis-Cremer B.Sc. (Hons), Ph.D. --
HIV Population Dynamics / Mary Kearney, John Coffin --
Part V: Prevention and Future Approaches. RT Inhibitors as Microbicides / Jan Balzarini.
責任: Stuart LeGrice, Matthias Gotte.
更多資訊:

摘要:

This book covers coordination of RT-associated DNA polymerase and ribonuclease H activities, mechanisms of action and perspectives on NRTIs and NNRTIs, strategies for targeting the RT enzyme and  再讀一些...

評論

讀者提供的評論
正在擷取GoodReads評論...
正在擷取DOGObooks的評論

標籤

成爲第一個
確認申請

你可能已經申請過這份資料。若還是想申請,請選確認。

連結資料


<http://www.worldcat.org/oclc/856550154>
library:oclcnum"856550154"
library:placeOfPublication
owl:sameAs<info:oclcnum/856550154>
rdf:typeschema:Book
rdfs:seeAlso
schema:about
schema:about
rdf:typeschema:Intangible
schema:name"MEDICAL / Internal Medicine"
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
rdf:typeschema:Intangible
schema:name"MEDICAL / Clinical Medicine"
schema:about
schema:about
rdf:typeschema:Intangible
schema:name"HEALTH & FITNESS / Diseases / General"
schema:about
rdf:typeschema:Intangible
schema:name"HIV Reverse Transcriptase."
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
rdf:typeschema:Intangible
schema:name"MEDICAL / Evidence-Based Medicine"
schema:bookFormatschema:EBook
schema:contributor
schema:contributor
schema:datePublished"2013"
schema:description"The Reverse Transcriptase (RT) of Human Immunodeficiency Virus Type 1 (HIV-1) arguably ranks amongst one of the most extensively studied retroviral enzymes. Heterologous expression and purification of HIV-1 RT in the early eighties, approval of the first nucleoside analogue RT inhibitor (NRTI) in 1987, discovery of resistance to RT inhibitors, approval of the first non-nucleoside analogue RT inhibitor (NNRTI) in 1996 and the various crystal structures of RT with and without bound substrate(s) and/or inhibitors represent only a few of the important milestones that describe the a bench-to-bedside success in the continuing effort to combat HIV-1 infection and its consequences. Nucleoside and nonnucleoside RT inhibitors remain important components in frequently used drug regimens to treat the infection. RT inhibitors also play important roles in recently validated strategies to prevent transmission of the virus. The relevance of HIV-1 RT as a drug target has simultaneously triggered interest in basic research studies aimed at providing a more detailed understanding of interactions between proteins, nucleic acids, and small molecule ligands in general terms. In light of the ever-growing knowledge on structure and function of HIV-1 RT, this enzyme serves as a valuable model system in efforts to develop novel experimental tools and to explain biochemical processes. This monograph is designed to provide an overview of important aspects in past and current HIV-1 RT research, with focus on mechanistic aspects and translation of knowledge into drug discovery and development. The first section includes chapters with emphasis placed on the coordination of the RT-associated DNA polymerase and ribonuclease H (RNase H) activities. The second covers mechanisms of action and future perspectives associated with NRTIs and NNRTIs, while the third section includes chapters focusing on novel strategies to target the RT enzyme. Chapters of the final part are intended to discuss mechanisms involved in HIV variability and the development of drug resistance. We hope that these contributions will stimulate interest, and encourage research aimed at the development of novel RT inhibitors. The lack of bona fide RNase H inhibitors with potent antiviral activity provides an example for challenges and opportunities in the field."
schema:exampleOfWork<http://worldcat.org/entity/work/id/1391348798>
schema:inLanguage"en"
schema:name"Human immunodeficiency virus reverse transcriptase : a bench-to-bedside success"
schema:sameAs<info:doi/10.1007/978-1-4614-7291-9>
schema:sameAs<http://dx.doi.org/10.1007/978-1-4614-7291-9>
schema:url<http://dx.doi.org/10.1007/978-1-4614-7291-9>
schema:url<http://site.ebrary.com/id/10736971>
schema:url<http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=612994>
schema:workExample
schema:workExample

Content-negotiable representations

關閉視窗

請登入WorldCat 

没有帳號嗎?你可很容易的 建立免費的帳號.